These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 16172127)
1. Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons. Tong A; Nguyen J; Lynch KW J Biol Chem; 2005 Nov; 280(46):38297-304. PubMed ID: 16172127 [TBL] [Abstract][Full Text] [Related]
2. HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing. Preussner M; Schreiner S; Hung LH; Porstner M; Jäck HM; Benes V; Rätsch G; Bindereif A Nucleic Acids Res; 2012 Jul; 40(12):5666-78. PubMed ID: 22402488 [TBL] [Abstract][Full Text] [Related]
3. A disease-associated polymorphism alters splicing of the human CD45 phosphatase gene by disrupting combinatorial repression by heterogeneous nuclear ribonucleoproteins (hnRNPs). Motta-Mena LB; Smith SA; Mallory MJ; Jackson J; Wang J; Lynch KW J Biol Chem; 2011 Jun; 286(22):20043-53. PubMed ID: 21507955 [TBL] [Abstract][Full Text] [Related]
4. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Lemaire R; Winne A; Sarkissian M; Lafyatis R Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085 [TBL] [Abstract][Full Text] [Related]
5. The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors. Rothstein DM; Saito H; Streuli M; Schlossman SF; Morimoto C J Biol Chem; 1992 Apr; 267(10):7139-47. PubMed ID: 1532394 [TBL] [Abstract][Full Text] [Related]
6. Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities. Pulido R; Schlossman SF; Saito H; Streuli M J Exp Med; 1994 Mar; 179(3):1035-40. PubMed ID: 7509359 [TBL] [Abstract][Full Text] [Related]
7. Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3. Vela E; Hilari JM; Roca X; Muñoz-Mármol AM; Ariza A; Isamat M RNA; 2007 Dec; 13(12):2312-23. PubMed ID: 17940137 [TBL] [Abstract][Full Text] [Related]
8. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans. Zilch CF; Walker AM; Timón M; Goff LK; Wallace DL; Beverley PC Eur J Immunol; 1998 Jan; 28(1):22-9. PubMed ID: 9485182 [TBL] [Abstract][Full Text] [Related]
9. A novel CD45 transcript involving the alternative splicing of a new exon is widely distributed in lymphoid tissues. Li D; Brackenridge S; Screaton GR Hum Immunol; 2004 Dec; 65(12):1539-45. PubMed ID: 15603882 [TBL] [Abstract][Full Text] [Related]
10. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. ten Dam GB; Zilch CF; Wallace D; Wieringa B; Beverley PC; Poels LG; Screaton GR J Immunol; 2000 May; 164(10):5287-95. PubMed ID: 10799890 [TBL] [Abstract][Full Text] [Related]
11. Splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a novel bipartite exonic enhancer/silencer element. Dirksen WP; Mohamed SA; Fisher SA J Biol Chem; 2003 Mar; 278(11):9722-32. PubMed ID: 12509424 [TBL] [Abstract][Full Text] [Related]
12. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing. Zahler AM; Damgaard CK; Kjems J; Caputi M J Biol Chem; 2004 Mar; 279(11):10077-84. PubMed ID: 14703516 [TBL] [Abstract][Full Text] [Related]
13. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence. Hovhannisyan RH; Carstens RP Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847 [TBL] [Abstract][Full Text] [Related]
14. HnRNP L represses exon splicing via a regulated exonic splicing silencer. Rothrock CR; House AE; Lynch KW EMBO J; 2005 Aug; 24(15):2792-802. PubMed ID: 16001081 [TBL] [Abstract][Full Text] [Related]
15. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B. Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309 [TBL] [Abstract][Full Text] [Related]
16. CD45 alternative exon expression in murine and human CD4+ T cell subsets. Rogers PR; Pilapil S; Hayakawa K; Romain PL; Parker DC J Immunol; 1992 Jun; 148(12):4054-65. PubMed ID: 1351092 [TBL] [Abstract][Full Text] [Related]
17. A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4. Topp JD; Jackson J; Melton AA; Lynch KW RNA; 2008 Oct; 14(10):2038-49. PubMed ID: 18719244 [TBL] [Abstract][Full Text] [Related]
18. Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA. Hayakawa M; Sakashita E; Ueno E; Tominaga S; Hamamoto T; Kagawa Y; Endo H J Biol Chem; 2002 Mar; 277(9):6974-84. PubMed ID: 11744705 [TBL] [Abstract][Full Text] [Related]
19. Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Oberdoerffer S; Moita LF; Neems D; Freitas RP; Hacohen N; Rao A Science; 2008 Aug; 321(5889):686-91. PubMed ID: 18669861 [TBL] [Abstract][Full Text] [Related]
20. Strong RNA splicing enhancers identified by a modified method of cycled selection interact with SR protein. Tian H; Kole R J Biol Chem; 2001 Sep; 276(36):33833-9. PubMed ID: 11454855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]